These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 6430722

  • 21. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
    Ben-Rafael Z, Benadiva CA, Ausmanas M, Barber B, Blasco L, Flickinger GL, Mastroianni L.
    Fertil Steril; 1987 Dec; 48(6):964-8. PubMed ID: 3119377
    [Abstract] [Full Text] [Related]

  • 22. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC, Jackson KV, Hornstein MD, Ginsburg ES.
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [Abstract] [Full Text] [Related]

  • 23. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [Abstract] [Full Text] [Related]

  • 24. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH, Sy L, Cannon W.
    Am J Obstet Gynecol; 1981 Jul 15; 140(6):629-35. PubMed ID: 6167169
    [Abstract] [Full Text] [Related]

  • 25. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program.
    Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I.
    Fertil Steril; 1987 Dec 15; 48(6):958-63. PubMed ID: 3119376
    [Abstract] [Full Text] [Related]

  • 26. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA, Moghissi KS.
    Obstet Gynecol; 1992 Jun 15; 79(6):983-7. PubMed ID: 1579327
    [Abstract] [Full Text] [Related]

  • 27. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE, Padilla SL, Bayati J, Baramki TA.
    Fertil Steril; 1990 Feb 15; 53(2):302-5. PubMed ID: 2105247
    [Abstract] [Full Text] [Related]

  • 28. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
    Elkind-Hirsch KE, Bello S, Esparcia L, Phillips K, Sheiko A, McNichol M.
    Fertil Steril; 2001 Apr 15; 75(4):700-4. PubMed ID: 11287022
    [Abstract] [Full Text] [Related]

  • 29. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB, Hutchison JS, Chandrasekher YA, Wolf DP, Stouffer RL.
    J Clin Endocrinol Metab; 1992 Aug 15; 75(2):502-7. PubMed ID: 1639951
    [Abstract] [Full Text] [Related]

  • 30. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
    Nilsson L, Wikland M, Hamberger L, Hillensjö T, Chari S, Sturm G, Daume E.
    J In Vitro Fert Embryo Transf; 1985 Mar 15; 2(1):17-22. PubMed ID: 3926921
    [Abstract] [Full Text] [Related]

  • 31. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL, Rebar RW, Schreiber JR, Vaitukaitis JL.
    Fertil Steril; 1983 Mar 15; 39(3):284-91. PubMed ID: 6402386
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 33. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z, Lang N, Amit A, Kahana L, Yoffe N.
    Fertil Steril; 1994 Sep 01; 62(3):456-60. PubMed ID: 8062938
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
    Pados G, Tarlatzis BC, Bontis J, Lagos S, Papadimas J, Spanos E, Mantalenakis S.
    Gynecol Endocrinol; 1995 Jun 01; 9(2):103-12. PubMed ID: 7502685
    [Abstract] [Full Text] [Related]

  • 35. Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG.
    Vuong LN, Pham TD, Ho VNA, Ho TM, Humaidan P, Andersen CY.
    Front Endocrinol (Lausanne); 2020 Jun 01; 11():137. PubMed ID: 32265836
    [Abstract] [Full Text] [Related]

  • 36. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD, Simon JA, Rifka SM, Falk RJ.
    Obstet Gynecol; 1989 Apr 01; 73(4):613-6. PubMed ID: 2494621
    [Abstract] [Full Text] [Related]

  • 37. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S, Kubota T, Aso T.
    Horm Res; 1992 Apr 01; 37 Suppl 1():59-63. PubMed ID: 1427631
    [Abstract] [Full Text] [Related]

  • 38. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J, Creus M, Fábregues F, Carmona F, Casamitjana R, Peñarrubia J, Rivera F, Vanrell JA.
    Gynecol Endocrinol; 1995 Mar 01; 9(1):51-8. PubMed ID: 7793300
    [Abstract] [Full Text] [Related]

  • 39. Steroid profiles during cycles with HCG stimulation of luteal function during in-vitro fertilization cycles.
    Blacker C, Cohen J, Castanier M, Debache C, Mandelbaum J, Plachot M, Scholler R.
    Hum Reprod; 1986 Feb 01; 1(2):69-73. PubMed ID: 3104394
    [Abstract] [Full Text] [Related]

  • 40. Effects of controlled ovarian hyperstimulation on oocyte quality in terms of the incidence of apoptotic granulosa cells.
    Kaneko T, Saito H, Takahashi T, Ohta N, Saito T, Hiroi M.
    J Assist Reprod Genet; 2000 Nov 01; 17(10):580-5. PubMed ID: 11209539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.